Prosecution Insights
Last updated: August 18, 2026

Examiner: SHOMER, ISAAC

Tech Center 1600 • Art Units: 1600 1612 1624

This examiner grants 63% of resolved cases

Performance Statistics

63.3%
Allow Rate
+3.3% vs TC avg
1,242
Total Applications
+30.3%
Interview Lift
1062
Avg Prosecution Days
Based on 1190 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
11.6%
§102 Novelty
45.9%
§103 Obviousness
25.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18649744 SHEAR-THINNING COMPOSITIONS FOR ABLATION Final Rejection Boston Scientific Scimed, Inc.
18606526 MEDICAL DEVICES INCLUDING THERAPEUTIC COATINGS FORMED FROM INDIVIDUALLY ENCAPSULATED THERAPEUTIC AGENT CRYSTALS Final Rejection Boston Scientific Scimed, Inc.
18699670 Microencapsulation Non-Final OA SYNGENTA CROP PROTECTION AG
18549645 DRY POWDER FORMULATIONS OF NUCLEIC ACID LIPID NANOPARTICLES Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18290135 MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES Non-Final OA The General Hospital Corporation
18570450 COSMETIC COMPOSITION COMPRISING AT LEAST ONE POLAR OIL, A POLYOL AND AT LEAST ONE HYDROPHILIC ACTIVE AGENT Final Rejection L'OREAL
18810596 METHOD FOR TREATING BLASTOCYSTIS Non-Final OA Imam Abdulrahman Bin Faisal University
18702663 HYDROGEL INCLUDING PHENOL DERIVATIVE-MODIFIED CELLULOSE AND USE THEREOF Final Rejection INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
18684335 BROAD SPECTRUM ANTI-MICROBIAL POLYMERIC COMPOSITION Non-Final OA CORNELL UNIVERSITY
18629296 VACCINE ADJUVANTS, TRANSFECTION REAGENTS, AND METHODS OF USING THE SAME Non-Final OA Wisconsin Alumni Research Foundation
18144382 IN VIVO IMMUNOIMAGING OF INTERFERON-GAMMA Final Rejection Wayne State University
17908086 DIFFUSIVITY CONTRAST AGENTS FOR MEDICAL IMAGING Non-Final OA Jinghua WANG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month